# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-130490
Filing Date
2026-03-30
Accepted
2026-03-30 08:35:41
Documents
89
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | tpst-20251231.htm iXBRL | 10-K | 3017171
2 | EX-4.1 | tpst-ex4_1.htm | EX-4.1 | 84125
3 | EX-10.12 | tpst-ex10_12.htm | EX-10.12 | 11343
4 | EX-10.25 | tpst-ex10_25.htm | EX-10.25 | 340201
5 | EX-10.26 | tpst-ex10_26.htm | EX-10.26 | 361563
6 | EX-10.27 | tpst-ex10_27.htm | EX-10.27 | 133310
7 | EX-10.28 | tpst-ex10_28.htm | EX-10.28 | 89715
8 | EX-10.29 | tpst-ex10_29.htm | EX-10.29 | 85449
9 | EX-23.1 | tpst-ex23_1.htm | EX-23.1 | 13074
10 | EX-31.1 | tpst-ex31_1.htm | EX-31.1 | 20679
11 | EX-31.2 | tpst-ex31_2.htm | EX-31.2 | 21859
12 | EX-32.1 | tpst-ex32_1.htm | EX-32.1 | 11240
13 | GRAPHIC | img81402019_0.jpg | GRAPHIC | 50973
14 | GRAPHIC | img81402019_1.jpg | GRAPHIC | 31431
15 | GRAPHIC | img81402019_2.jpg | GRAPHIC | 223246
16 | GRAPHIC | img81402019_3.jpg | GRAPHIC | 216537
17 | GRAPHIC | img81402019_4.jpg | GRAPHIC | 104315
18 | GRAPHIC | img81402019_5.jpg | GRAPHIC | 67150
19 | GRAPHIC | img81402019_6.jpg | GRAPHIC | 97868
20 | GRAPHIC | img81402019_7.jpg | GRAPHIC | 237726
21 | GRAPHIC | img81402019_8.jpg | GRAPHIC | 313680
22 | GRAPHIC | img81402019_9.jpg | GRAPHIC | 154000
| Complete submission text file | 0001193125-26-130490.txt |  | 15007977

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
23 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | tpst-20251231.xsd | EX-101.SCH | 1259813
93 | EXTRACTED XBRL INSTANCE DOCUMENT | tpst-20251231_htm.xml | XML | 1412132

Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35890 | Film No.: 26810105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)